share_log

科濟藥業-B：董事名單及其角色及職能

CARSGEN-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

Hong Kong Stock Exchange ·  Apr 29 10:40
Summary by Moomoo AI
科濟藥業控股有限公司（「本公司」）於2024年4月29日公布了董事會成員名單及其在董事會下設的三個委員會中的角色及職能。執行董事包括李宗海博士（主席）、王華茂博士和蔣華博士；非執行董事為郭炳森先生、謝榕剛先生和郭華清先生；獨立非執行董事則有顏光美博士、周文博士和趙向可女士。審計委員會、薪酬委員會和提名及企業管治委員會的主席分別為趙向可女士、周文博士和周文博士。該公告確認了公司治理架構的完善和對公司治理規範的遵循。
科濟藥業控股有限公司（「本公司」）於2024年4月29日公布了董事會成員名單及其在董事會下設的三個委員會中的角色及職能。執行董事包括李宗海博士（主席）、王華茂博士和蔣華博士；非執行董事為郭炳森先生、謝榕剛先生和郭華清先生；獨立非執行董事則有顏光美博士、周文博士和趙向可女士。審計委員會、薪酬委員會和提名及企業管治委員會的主席分別為趙向可女士、周文博士和周文博士。該公告確認了公司治理架構的完善和對公司治理規範的遵循。
KOJI PHARMACEUTICAL HOLDINGS LIMITED (THE “COMPANY”) ANNOUNCED ON 29 APRIL 2024 THE LIST OF BOARD MEMBERS AND THEIR ROLES AND FUNCTIONS IN THE THREE COMMITTEES UNDER THE BOARD OF DIRECTORS. THE EXECUTIVE DIRECTORS ARE DR. LEE ZONGHAI (CHAIRMAN), DR. WANG HUAMAO AND DR. JIANG HUA; THE NON-EXECUTIVE DIRECTORS ARE MR. KWOK PING-SEN, MR. SHIE YANGGANG AND MR. KWOK HUA-QING; THE INDEPENDENT NON-EXECUTIVE DIRECTORS ARE DR. YAN GUANGMEI, DR. ZHOU WEN AND MS. ZHAO SIUNG KO. The Chairman of the Audit Committee, the Remuneration Committee and the Nomination and Corporate Governance Committee are Ms. Zhao, Dr. Zhou Wen and Dr. Zhou Wen. THE ANNOUNCEMENT CONFIRMS THE INTEGRITY OF THE CORPORATE GOVERNANCE FRAMEWORK AND COMPLIANCE WITH CORPORATE GOVERNANCE REGULATIONS.
KOJI PHARMACEUTICAL HOLDINGS LIMITED (THE “COMPANY”) ANNOUNCED ON 29 APRIL 2024 THE LIST OF BOARD MEMBERS AND THEIR ROLES AND FUNCTIONS IN THE THREE COMMITTEES UNDER THE BOARD OF DIRECTORS. THE EXECUTIVE DIRECTORS ARE DR. LEE ZONGHAI (CHAIRMAN), DR. WANG HUAMAO AND DR. JIANG HUA; THE NON-EXECUTIVE DIRECTORS ARE MR. KWOK PING-SEN, MR. SHIE YANGGANG AND MR. KWOK HUA-QING; THE INDEPENDENT NON-EXECUTIVE DIRECTORS ARE DR. YAN GUANGMEI, DR. ZHOU WEN AND MS. ZHAO SIUNG KO. The Chairman of the Audit Committee, the Remuneration Committee and the Nomination and Corporate Governance Committee are Ms. Zhao, Dr. Zhou Wen and Dr. Zhou Wen. THE ANNOUNCEMENT CONFIRMS THE INTEGRITY OF THE CORPORATE GOVERNANCE FRAMEWORK AND COMPLIANCE WITH CORPORATE GOVERNANCE REGULATIONS.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more